The IPO Party Is Cut Short
The third quarter started off in high spirits but ended with a hangover. During the quarter, 39 deals raised $10.8 billion, down slightly from last year, but above the historical average. Healthcare and tech companies again dominated IPO issuance. Software unicorns confirmed that there is still demand for high-growth tech stocks. On the other hand, the two largest offerings were both high-growth, high-profile disappointments.
Download a preview of our 3Q19 US IPO Market Review here, or sign up for our mailing list to get the market reviews sent right to your inbox.
